Chitosan-based systems

Absorbable and Biodegradable Polymers

Volumn , Issue , 2003, Pages 77-90

  Shalaby, Shalaby W ^a   Dubose, John A ^a   Shalaby, Marc ^b  

^a Poly Med Inc   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056051841     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Sandford, P. A. and Steinnes, A., Biomedical applications of high-purity chitosan, in Water Soluble Polymers, Vol. 467, Shalaby, S. W., Ed., ACS Symposium Series, Vol. 467, 1991, chap. 28.
2. Thomas, C. and Sharma, P., Chitosan as a biomaterial, Biomater. Artif. Cells Artif. Org., 18, 1, 1990.
3. Tomihata, K. and Ikada, Y., In vitro and in vivo degradation of films of chitin and its deacetylated derivatives, Biomaterials, 18, 567, 1997.
4. Muzzarelli, R. A., Biochemical significance of exogenous chitins, chitosan in animals, patients, Carbohydr. Polym., 20, 7, 1993.
5. Kimura, Y., Biodegradable polymers, in Biomedical Applications of Polymeric Materials, Tsuruta, T., Hayashi, T., Kataoka, K., Ishihara, K., and Kimura, Y., Eds., CRC Press, Boca Raton, FL, 1993, chap 3.
6. Rao, S. B. and Sharma, C. P., Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential, J. Biomed. Mater. Res., 34, 21, 1997.
7. Tayab, F. A., Hydrophobic chitosan in controlled release delivery systems, M.S. Thesis, Department of Bioengineering, Clemson University, Clemson, SC, 1995.
8. Shalaby, S. W. and Ignatious, F. S., Ionic Molecular Conjugates of Biodegradable Fully n-Acylated Derivatives of Poly(2-amino-2-deoxy-d-glucose) and Bioactive Polypeptides, U.S. Patent (to Biomeasure, Inc.) 5,665,702, 1997.
9. Shalaby, S. W. and Ignatious, F., Ionic Molecular Conjugates of Biodegradable Fully n-Acylated Derivatives of Poly(2-amino-2-deoxy-d-glucose) and Bioactive Polypeptides, U.S. Patent (to Biomeasure, Inc.) 5,821,221, 1998.
10. Shalaby, S. W., Jackson, S. A., Ignatious, F. S. and Moreau, J. P., Ionic Molecular Conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides, U.S. Patent (to Biomeasure, Inc.) 6,479,457, 2002.
11. Shalaby, S. W., Poly-Med, Inc., internal reports, 1996 and 1998.
12. Song, Y., Onishi, H. and Nagai, T., Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethylchitin, Chem. Pharm. Bull., 40(10), 2822, 1992.
13. Ono, K., Saito, Y., Yura, H., Ishikawa, K., Kurita, A., Akaike, T. and Ishihara, M., Photocrosslinkable chitosan as a biological adhesive, J. Biomed. Mater. Res., 49, 289, 2000.
14. Hirano, S., Zhang, M., Nakagawa, M. And Miyata, T., Wet spun chitosancollagen fibers, their chemical N-modifications, and blood compatibility, Biomaterials, 21, 997, 2000.
15. Shalaby, S.W., Hydrogel-Forming, Self-Solvating Absorbable Polyester Copolymers, and Methods for Use Thereof, U.S. Patent (to Poly-Med, Inc.) Composition 5,612,052, 1997.
16. Jeong, B., Bae, Y. J., Lee, B. S. and Kim, S. W., Nature, 388, 860, 1997.
17. Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. C., Hoemann, C. D., Leroux, J. C., Atkinson, B. L., Binette, F. and Selmani, A., Novel injectable neutral solutions of chitosan form biodegradable gels in situ, Biomaterials, 21, 2155, 2000.
18. Molinaro, G., Leroux, J. C., Damas, J. and Adam, A., Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials, Biomaterials, 23, 2717, 2002.
19. Tan, T. W., Hu, B., Jin, X. H. and Zhang, M., Release behavior of ketoprofen in chitosan/alginate microcapsules, J. Bioact. Biocomp. Polym., 2003 (in press).
20. Sung, H. W., Chang, Y., Chiu, C. T., Chen, C. N. and Liang, H. C., Crosslinking characteristics and mechanical properties of a bovine pericardium fixed with a naturally occurring crosslinking agent, J. Biomed. Mater. Res., 47, 116, 1999.
21. Mi, F. L., Tan, Y. C., Liang, H. F. and Sung, H. W., In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant, Biomaterials, 23, 181, 2002.
22. Zhang, Y. and Zhang, M., Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release, J. Biomed. Mater. Res., 62, 378, 2002.
23. Korkusuz, F., Uchida, A., Shinto, Y., Araki, N., Inoue, K. and Ono, K., Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites, J. Bone Joint Surg., 75-B, 111, 1993.
24. Chu, C. H., Kumagai, H. and Nakamura K., Application of polyelectrolyte complex gel composed of xanthan and chitosan to the immobilization of Corynebacterium glutamicum, J. Appl. Polym. Sci., 60, 1041, 1996.
25. Chellat, F., Tabrizian, M., Dumitriu, S., Chornet, E., Magny, P., Rivard, C. H. and Yahia, L. H., In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex, J. Biomed. Mater. Res., 51, 107, 2000.
26. Chellat F., Tabrizian, M., Dumitriu, S., Chornet, E., Rivard, C. H. and Yahia, L. H., HPLC analysis of chitosan-xanthan microspheres degradation, Proc 18th Can. Biomater. Soc. Conf., 1998.
27. Van der Lubben, I. M., Verhoef, J. C., Van Aelst, A. C., Borchard, G. and Junginger, H. E., Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer’s patches, Biomaterials, 22, 687, 2001.
28. Fasano, A., Innovative strategies for the oral delivery of drugs and peptides, TiBtech., 16, 152, 1998.
29. Lydyard, P. and Grossi, C., Secondary lymphoid organs and tissues, in Immunology, Roitt, I., Brostoff, J., and Male, D., Eds., Mosby, London, 1998, 33.
30. Halpern, A. C., Retinoids and the chemoprevention of melanoma, in Advances in the Biology and Treatment of Cutaneous Melanoma, Meeting Abstracts, Boston, MA, November 6 and 7, 1998.
31. Gilchrest, B. A., Treatment of photodamage with topical tretinoin: an overview, J. Am. Acad. Dermatol., 36, S27, 1997.
32. Stan-Posthuma, J. J., Vink, J., le Cessie, S., Bruijn, J. A., Bergman, W. and Pavel, S., Effect of topical tretinoin under occlusion on atypical naevi, Melanoma Res., 8, 539, 1998.
33. Cattaneo, M. V. and Demeirre, M. F., Biodegradable chitosan for topical delivery of retinoic acid, Drug Delivery Techno., 1, 45, 2001.
34. Barth, R. F. and Soloway, A. H., Boron neutron capture therapy of primary and metastatic brain tumors, Mol. Chem. Neuropathol., 21, 139, 1994.
35. Mishima, Y., Ichihashi, M., Hatta, S., Honda, C., Yamamura, K. and Nakagawa, T., New thermal neutron capture therapy for malignant melanoma: melanogenesis- seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial, Pigment Cell Res., 2, 226 1989.
36. Greenwood, R. C., Reich, C. W., Baader, H. A., Koch, H. R., Breitig, D., Schult, O. W. B., Fogelberg, B., Backlin, A., Mampe, W., von Edigy, T. and Schreckenbach, K., Collective and two-quasiparticle states in 158Gd observed through study of radiative neutron capture in 157Gd, Nucl. Phys., A304, 327, 1978.
37. Akine, Y., Tokita, N., Tokuuye, K., Satoh, M., Churei, H., Pechoux, C. L., Kobayashi, T. and Kanda, K., Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy, Jpn. J. Cancer Res., 84, 841, 1993.
38. Tokumitsu, H., Ichikawa, H. and Fukumori, Y., Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization, Pharma. Res., 16, 1830, 1999.
39. Fujii, S., Yokoyama, T., Ikegaya, K., Sato, F. and Yoko, N., Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs, J. Pharm. Pharmacol., 37, 545, 1985.
40. Langguth, P., Merkle, H. P. and Amidon, G. L., Oral absorption of peptides: The effect of absorption site and enzyme inhibition on the systemic availability of metkephamid, Pharm. Res., 11, 528, 1994.
41. Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M. and Muranishi, S., Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats, Pharm. Res., 11, 1496, 1994.
42. Morishita, L., Morishita, M., Takayama, K., Machida, Y. and Nagai, T., Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats, Int. J. Pharm., 78,9, 1992.
43. Bernkop-Schnorch, A. and Pasta, M., Intestinal peptide and protein delivery: Novel bioadhesive drug-carrier matrix shielding from enzymatic attack, J. Pharm. Sci., 4, 430, 1998.
44. Reseland, J. E., Holm, H., Jacobsen, M. B., Jenssen, T. G. and Hanssen, L. E., Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion, Hum. Clin. Nutr., 126, 634, 1996.
45. Richardson, S., Kolbe, H. V. J. and Duncan, R., Evaluation of highly purified chitosan as a potential gene delivery vector, Proc. Int. Symp. Contr. Rel. Bioact. Mater., 24, 649, 1997.
46. MacLaughlin, F. C., Mumper, R. J., Wang, J., Tagliaferri, J. M., Gill, I., Hinchcliffe, M. and Rolland, A. P., Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, J. Cont. Rel., 56, 259, 1998.
47. Ishihara, M., Nakanishi, K., Ono, K., Sato, M., Kikuchi, M., Saito, Y., Yura, H., Matsui, T., Hattori, H., Uenoyama, M. and Kurita, A. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process, Biomaterials, 23, 833, 2002.
48. Wang, X., Ma, J., Wang, Y. and He, B., Structural characterization of phosphorylated chitosan and their applications as effective additives to calcium phosphate cement, Biomaterials, 22, 2247, 2001.
49. Jianchun, L., Yinghui, Z., Haipeng, G., Yandao, G., Nanming, Z. and Xiufang, Z., A primary study of using chitosan for nerve repair conduit, in 5th IUMRS Int. Conf. Adv. Mater., Beijing, China, 1999.
50. Haipeng, G., Yinghui, Z., Jianchun, L., Yandao, G., Nanming, Z. and Xiufang, Z., Studies on nerve cell affinity of chitosan-derived materials, J. Biomed. Mater. Res., 52, 285, 2000.
51. Hirano, S. and Noishiki, Y., The blood compatibility of chitosan and N-acylchitosans, J. Biomed. Mater. Res., 19, 413, 1984.
52. Klokkevold, P. R., Vandemark, L., Kenney, E. B. and Bernard, G. W., Osteogenesis enhanced by chitosan (poly-N-acetyl glucosamineglycan) in vitro, J. Periodontol., 67, 1170, 1996.
53. Muzzarelli, R., Baladasarre, V., Conti, F., Ferrara, P., Biagini, G., Gazzanelli, G. and Vasi, V., Biological activity of chitosan: ultrastructural study, Biomaterials, 9, 247, 1988.
54. Moskowitz, R. W., Schwartz, H. J., Michel, B., Ratnoff, O. D. and Astrup, T., Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: possible patho-physiologic implications, J. Lab. Clin. Med., 76, 790, 1970.
55. Lu, J. X., Prudhommeaux, F., Meunier, A., Sedel, L. and Guillemin, G., Effects of chitosan on rat knee cartilages, Biomaterials, 20, 1937, 1999.
56. Prudden, J. G., Migel, P., Hanson, P., Friedrich, L. and Balassa, L., The discovery of a potent pure chemical wound-healing accelerator, Am. J. Surg., 119, 560, 1970.
57. Scott, D. W., Miller, W. H. and Griffin, C. E., Muller and Kirk’s Small Animal Dermatology, W. B. Saunders, PA, 1995, 262.
58. Cassatella, M. A., The production of cytokines by polymorphonuclear neutrophils, Immunol. Today, 16, 21, 1995.
59. Ueno, H., Murakami, M., Okumura, M., Kadosawa, T., Uede, T. and Fujinaga, T., Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes, Biomaterials, 22, 1667, 2001.
60. Oldberg, A., Franzen, A. and Heinegard, D., Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence, Proc. Natl. Acad. Sci., USA, 83, 8819, 1986.
61. Somerman, M. J., Prince, C. W., William, T. B., Foster, R. A., Moehring, J. M and Sauk, J. J., Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells, Matrix, 9, 49, 1989.
62. Miyauchi A., Alvarez, J., Greenfield, E. M., et al., Recognition of osteopontin and related peptides by an avb3 integrin stimulates immediate cell signals in osteoclasts, J. Biol. Chem., 266, 20369, 1991.
63. Ross, F. P., Chappel, J., Alvarez, J. I. et al., Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclase integrin avb3 potentiate bone resorption, J. Biol. Chem., 268,9901, 1993.
64. Senger, D. R., Perruzzi, C. A., Papadopousos-Sergiou, A. and Van De Water, L., Adhesive properties of osteopontin: regulation by a naturally occurring thrombin- cleavage in close proximity to the GRGDS cell-binding domain, Mol. Biol. Cell, 5, 565, 1994.
65. Takeuchi, H., Yasuji, T., Yamamoto, H. and Kawashima, Y., Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function, Pharm. Res., 17, 94, 2000.
66. Kim, H. J., Lee, H. C., Oh, J. S., Sin, B. A., Oh, C. S., Park, R. D., Yang, K. S. and Cho, C. S., Polyelectrolyte complex composed of chitosan and sodium alginate for wound dressing application, J. Biomater. Sci., Polym. Ed., 10, 543, 1999.
67. Gaserod, O., Smidsrod, O. and Skjak-Braek, G., Microcapsules of alginatechitosan— I. A quantitative study of the interaction between alginate and chitosan, Biomaterials, 19, 1815, 1998.
68. Chandy, T., Mooradian, D. L. and Rao, G. H., Chitosan/polyethylene glycolalginate microcapsules for oral delivery of hirudin, J. Appl. Polym. Sci., 70, 2143, 1998.
69. Wang, L., Khor, E., Wee, A. and Lim, L. Y., Chitosan-alginate PEC membrane as a wound dressing: assessment of incisional wound healing, J. Biomed. Mater. Res., Appl. Biomater., 63, 610, 2002.
70. Zhu, H., Ji, J., Lin, R., Gao, C., Feng, L. and Shen, J., Surface engineering of poly(D,L-lactic acid) by entrapment of chitosan-based derivatives for the promotion of chondrogenesis, J. Biomed. Mater. Res., 62, 532, 2002.
71. Yannas, I. V., Burke, J. F., Gordon, P. L. and Huang, C., Collagen-like membranes for synthetic skin, Ger. Offen., 2631, 909, 1977.
72. Yannas, I. V., Burke, J. F., Qrigill, D. P. and Skraubut, E. M., Wound tissue can utilize a polymeric template to synthesize a functional extension of skin, Science, 215, 174, 1982.
73. Heimbach, D., Luterman, A. and Burke, J. F. et al., Artificial dermis for major burns: a multi-center randomized clinical trial, Ann. Surg., 208, 313, 1988.
74. Ma, J., Wang, H., He, B. and Chen, J., A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts, Biomaterials, 22, 331, 2001.